Efficacy News and Research

RSS
Insights into molecular folding of AAT protein will help develop new therapies for alpha-1 antitrypsin deficiency

Insights into molecular folding of AAT protein will help develop new therapies for alpha-1 antitrypsin deficiency

SARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgA

SARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgA

What is the role of psychedelic drugs in the treatment of psychiatric disorders?

What is the role of psychedelic drugs in the treatment of psychiatric disorders?

Scientists identify papain-like protease inhibitor against COVID-19

Scientists identify papain-like protease inhibitor against COVID-19

IU researchers evaluate the efficacy of a failed clinical trial drug for Alzheimer's using rigorous pipeline

IU researchers evaluate the efficacy of a failed clinical trial drug for Alzheimer's using rigorous pipeline

Research reveals molecular clues associated with traumatic brain injury

Research reveals molecular clues associated with traumatic brain injury

Researchers discover a ‘weak spot’ that makes multi-drug resistant tumors vulnerable

Researchers discover a ‘weak spot’ that makes multi-drug resistant tumors vulnerable

New biomimetic formulation developed to tackle glioblastoma multiforme

New biomimetic formulation developed to tackle glioblastoma multiforme

Antibodies' neutralization efficacy against Omicron variants BA.1 And BA.2 wanes rapidly, study finds

Antibodies' neutralization efficacy against Omicron variants BA.1 And BA.2 wanes rapidly, study finds

Study opens up new possible treatment methods for patients with urinary tract infections

Study opens up new possible treatment methods for patients with urinary tract infections

Alzheimer's disease and anti-amyloid therapeutic approaches

Alzheimer's disease and anti-amyloid therapeutic approaches

A different approach to build a more durable, broadly effective COVID-19 vaccine

A different approach to build a more durable, broadly effective COVID-19 vaccine

Phase 2a clinical trial describes safety and efficacy of dendrimer nanotherapy in severe COVID-19 patients

Phase 2a clinical trial describes safety and efficacy of dendrimer nanotherapy in severe COVID-19 patients

FDA clears IND application for MD Anderson-sponsored Phase I clinical study of OBX-115 therapy

FDA clears IND application for MD Anderson-sponsored Phase I clinical study of OBX-115 therapy

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Myocardial fibrosis linked to worse cardiovascular outcomes in patients with hypertension

Myocardial fibrosis linked to worse cardiovascular outcomes in patients with hypertension

Kessler Foundation researchers receive NJHF grants to advance research in neurological disabilities

Kessler Foundation researchers receive NJHF grants to advance research in neurological disabilities

Is monkeypox a global public-health emergency?

Is monkeypox a global public-health emergency?

High-level resistance of SARS-CoV-2 BA.4 against neutralizing antibodies

High-level resistance of SARS-CoV-2 BA.4 against neutralizing antibodies

Fourth dose of Pfizer mRNA COVID vaccine protective against variants and symptomatic infection

Fourth dose of Pfizer mRNA COVID vaccine protective against variants and symptomatic infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.